Voting Opens to Select the Winner of the 2011 IN Cell Analyzer Image Competition

GE Healthcare

GE Healthcare Life Sciences announced that voting for the 2011 IN Cell Analyzer Image Competition is now open. Both scientists and the wider public are invited to choose their favourite from 30 shortlisted images submitted by researchers worldwide.

When making their selection, voters can consider the beauty of the image, their interest in the science behind it, or a combination of the two. The winning entrants from each region (Americas, Europe and Asia/Rest of World) will be invited to New York to see their images projected on NBC's high definition screen in Times Square.

Carmen Laethem, Aerie Pharmaceuticals, a previous winner and a judge on the 2011 shortlisting panel, said, "The images of cells that scientists produce every day on the IN Cell Analyzer can be captivatingly beautiful, some reminiscent of scenes from nature or even evoking the visual style of artists such as Jackson Pollock or Miró. Behind that beauty lies valuable data which enables researchers to, for example, better understand the mechanisms behind disease at the cellular level or conduct early screens for potential new therapies."

Dr Amr Abid, General Manager of Cell Technologies, GE Healthcare Life Sciences, said, "Once again, we have an exciting range of images from around the world. We're proud of how they showcase the capabilities of cellular imaging with our IN Cell Analyzer systems but also believe scientists should share the images with friends and family to inspire them with the beauty of cells and provide an accessible introduction to their own research."

To view the shortlisted images and vote for your favourite, please visit:
http://www.gelifesciences.com/incellcompetition

Related news articles:

About the 2011 IN Cell Analyzer Image Competition
The IN Cell Image Competition, supported by BioTechniques, celebrates the outstanding research enabled by the superior image quality that IN Cell Analyzer systems deliver. Voting starts on 7 November and continues online until mid-December. Attendees at two conferences (ASCB, December 3-7, USA and MBSJ, December 13-16, Japan) will also be invited to vote for their favourite. The votes will be combined to select 3 winners, one from each region (Americas, Europe, Asia/Rest of World). Details of the judging panel can be found here and full terms and conditions can be found here.

About GE Healthcare's IN Cell Analyzer system
IN Cell Analyzer automated high content cell imagers, IN Cell Investigator image analysis software and IN Cell Miner data management software combine to provide a system that represents a total solution for high content sub cellular analysis in research and drug discovery. High-performance hardware, powerful software, and expert instrument and applications support are harmonized to transform the cellular workflow.

IN Cell Analyzer 2000 is a highly flexible, lamp-based high-content imaging instrument impressively enabling for a wide range of assays and techniques. The latest addition to the IN Cell Analyzer family, IN Cell Analyzer 6000 is a high-end, laser based confocal imaging platform for the most demanding high-content assays and screens. Featuring a novel and proprietary optical system that incorporates an iris-like variable aperture design and next-generation sCMOS technology, IN Cell Analyzer 6000 balances speed and image quality for challenging and variable assays.

About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.

Most Popular Now

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...